Cargando…
Harmine targets inhibitor of DNA binding‐2 and activator protein‐1 to promote preosteoclast PDGF‐BB production
Osteoporosis is one of the most common metabolic bone diseases affecting millions of people. We previously found that harmine prevents bone loss in ovariectomized mice via increasing preosteoclast platelet‐derived growth factor‐BB (PDGF‐BB) production and type H vessel formation. However, the molecu...
Autores principales: | Huang, Jie, Li, You‐You, Xia, Kun, Wang, Yi‐Yi, Chen, Chun‐Yuan, Chen, Meng‐Lu, Cao, Jia, Liu, Zheng‐Zhao, Wang, Zhen‐Xing, Yin, Hao, Hu, Xiong‐Ke, Wang, Zheng‐Guang, Zhou, Yong, Xie, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184727/ https://www.ncbi.nlm.nih.gov/pubmed/33960660 http://dx.doi.org/10.1111/jcmm.16562 |
Ejemplares similares
-
PDGF-BB secreted by preosteoclasts induces CD31(hi)Emcn(hi) vessel subtype in coupling osteogenesis
por: Xie, Hui, et al.
Publicado: (2014) -
PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly
Publicado: (1992) -
Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis: PDGF-BB mediated by estradiol in women
por: Tang, Lanhua, et al.
Publicado: (2017) -
Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB
por: Gao, Si-yong, et al.
Publicado: (2017) -
A Promising Candidate in Tendon Healing Events—PDGF-BB
por: Chen, Yixuan, et al.
Publicado: (2022)